Integrated Research's annual performance and strategic plans

Integrated Research (ASX:IRI) held its Y2024 Annual General Meeting on November 25, 2024. The company reported strong financial performance with a notable increase in Total Contract Value, especially in the Americas and Europe, and a significant rise in Net Profit After Tax. Integrated Research also reinstated its dividend, declaring a 2.0 cents per share fully franked dividend.

Integrated Research's strategic outlook and future goals

Integrated Research (ASX:IRI) has shown a strong financial performance in Y2024, with a 22% increase in Total Contract Value and a 19% rise in revenue. The company experienced a significant surge in NPAT, excluding a $31.8M impairment. A growth-oriented board has been appointed, focusing on customer-led innovation and strategic mergers and acquisitions. Integrated Research is positioned in the expanding Observability market, aiming to differentiate its offerings between on-premises and cloud solutions. With a robust global client base, the company plans to launch new product capabilities in FY25, despite anticipating a softer contract renewal value. Integrated Research aspires to become the leading independent provider of technology and infrastructure intelligence, aiming for sustained growth through innovation and strategic financial management.

Executive insights on Integrated Research's performance

The company reported a year of strong financial performance and strategic realignment aimed at driving growth. Key highlights for the fiscal year included a robust increase in Total Contract Value (TCV), especially in the Americas and Europe, and a significant rise in Net Profit After Tax (NPAT). The company also re-instated its dividend, declaring a 2.0 cents per share fully franked dividend.